A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer

Conditions: HPV-Related Cervical Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma Interventions: Drug: Two IM injections Lenti-HPV-07; Drug: One IM injection Lenti-HPV-07 Sponsors: Theravectys S.A. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials